Skip to main content
Clinical Trials/JPRN-UMIN000053977
JPRN-UMIN000053977Not yet recruitingUnknown

Postoperative delirium prevention and analgesic effects of continuous postoperative administration of dexmedetomidine for craniotomy - Delirium prevention and analgesic effect of dexmedetomidine

Shinonoi general hospital0 sites30 target enrollmentStarted: April 1, 2024Last updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • emergency surgery patient Patients with ASA-PS3 or higher Patients with contraindications to haloperidol, such as Parkinson's disease Patients with renal impairment and contraindication to NSAIDs Patients who are allergic to other drugs used Patients who cannot consent minor

Investigators

Sponsor
Shinonoi general hospital

Similar Trials